Dibucaine Hydrochloride is the water-soluble salt form of a well-characterised quinoline carboxamide local anaesthetic compound. It is widely recognised in laboratories as the selective inhibitor used in the classical dibucaine number assay for butyrylcholinesterase variants. Researchers also employ it as a reference compound in enzyme inhibition kinetics and membrane interaction studies. Supplied by TCI in 5 g and 25 g sizes, the material is intended for research and experimental use only.
—
| Brand | — |
|---|---|
| CAS number | — |
| Molecular formula | — |
| Purity | — |
| Category | — |
| Pack sizes | — |
| Physical form | — |
| Storage | — |
—
- Yamadori et al. (2009). Allergic contact dermatitis from dibucaine hydrochloride, chlorpheniramine maleate, and naphazoline hydrochloride in an over‐the‐counter topical antiseptic. Contact Dermatitis doi:10.1111/j.1600-0536.2009.01556.x
- LaPlanche (1991). 13C NMR Chemical Shift Assignments in Dibucaine and Dibucaine Hydrochloride Determined by Two-Dimensional NMR Spectroscopy. Spectroscopy Letters doi:10.1080/00387019108020651
- YOKOYAMA (1997). Surface Potential of Mixed Micelles Composed of Dibucaine Hydrochloride and Heptaethylene Glycol Dodecyl Ether.. Chemical and Pharmaceutical Bulletin doi:10.1248/cpb.45.2104
References were compiled automatically from Crossref and every DOI was verified to exist. AMI Scientific is not affiliated with the authors or the publishers.

